Among CD11b+ cells, percentages of CD11b+Ly6Chi (M-MDSC), CD11b+Ly6CloLy6G+ (PNM-MDSC) cells and F4/80+ tumor-associated macrophages (TAM) were not significantly different between the two groups (Fig. 2g and Supplementary Fig. 2b). This evidence concerns the gene ITGAM and neoplasm.